Friále is a global venture capital firm that primarily invests in seed-stage startups worldwide. They typically make initial investments at the seed stage with the intention of following on as companies grow. The firm's investment approach is founder-centric, drawing from their own experiences as entrepreneurs to provide the kind of support they would have wanted as founders.
Notable portfolio companies include BillionToOne, C16 Biosciences, and Lively, Inc., which have raised significant funding. Friále offers a unique value proposition by combining their global investment focus with a founder-first mentality, aiming to be the type of investors they would want on their own cap table. Their portfolio spans diverse sectors including biotech, fintech, and e-commerce.
Friale - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments28
Current Portfolio Count19
Total Portfolio Exits1
Top Investment Stages
Seed21 (75.0%)
Series A4 (14.3%)
Pre-Seed2 (7.1%)
Series B1 (3.6%)
Stage Mix
Seed 75%Series A 14%Pre-Seed 7%Series B 4%
Concentration shown as share of disclosed investments by stage.
Friale - Classification
- Also Known As
- Friale LLC
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
Show 8 more industry codes
- NAICS
- 540000Professional, Scientific, and Technical Services
- 525000Funds, Trusts, and Other Financial Vehicles
- 541000Professional, Scientific, and Technical Services
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 7300Business Services
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified